MMS, IFA, and MMS+IFA Supplementation in Pregnant Women
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorSindh Institute of Child Health and Neonatology
About this trial
This study aims to compare the effectiveness of Multiple Micronutrient Supplementation (MMS), Iron-Folic Acid (IFA) supplementation, and combined MMS+IFA supplementation among pregnant women. Maternal anemia and micronutrient deficiencies are common during pregnancy and can adversely affect both maternal and neonatal health outcomes.
A total of 402 pregnant women with gestational age of 20 weeks or less will be randomly assigned to receive MMS, IFA, or combined MMS+IFA supplementation. Participants will be followed throughout pregnancy until delivery. Maternal hemoglobin levels, maternal compliance with supplementation, and neonatal outcomes including birth weight, preterm birth, APGAR scores, and congenital anomalies will be assessed.
The findings of this study will provide evidence to guide antenatal nutrition policies and practices in Pakistan.
Eligibility criteria
Qualifiers
Pregnant women aged 18 years or older
Gestational age ≤20 weeks at enrollment
Singleton pregnancy
Hemoglobin concentration ≥10 g/dL at baseline
Disqualifiers
Severe anemia requiring injectable treatment (hemoglobin <7 g/dL)
Pre-existing diabetes mellitus
Pre-existing hypertension
Renal disease
Trial design
Treatments tested in this trial
- Multiple Micronutrient Supplementation (MMS)
- Iron-Folic Acid (IFA)
Treatment groups
402 Participants
are divided into 3 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov